450 related articles for article (PubMed ID: 24946073)
1. APOE and BDNF Val66Met polymorphisms combine to influence episodic memory function in older adults.
Ward DD; Summers MJ; Saunders NL; Janssen P; Stuart KE; Vickers JC
Behav Brain Res; 2014 Sep; 271():309-15. PubMed ID: 24946073
[TBL] [Abstract][Full Text] [Related]
2. Variations in the APOE allele or BDNF Val66Met polymorphism are not associated with changes in cognitive function following a tertiary education intervention in older adults: the Tasmanian Healthy Brain Project.
Thow ME; Summers MJ; Summers JJ; Saunders NL; Vickers JC
Neurobiol Aging; 2017 Jul; 55():175-176. PubMed ID: 28438485
[TBL] [Abstract][Full Text] [Related]
3. Lack of neural compensatory mechanisms of BDNF val66met met carriers and APOE E4 carriers in healthy aging, mild cognitive impairment, and Alzheimer's disease.
Gomar JJ; Conejero-Goldberg C; Huey ED; Davies P; Goldberg TE;
Neurobiol Aging; 2016 Mar; 39():165-73. PubMed ID: 26923413
[TBL] [Abstract][Full Text] [Related]
4. BDNF and COMT polymorphisms have a limited association with episodic memory performance or engagement in complex cognitive activity in healthy older adults.
Stuart K; Summers MJ; Valenzuela MJ; Vickers JC
Neurobiol Learn Mem; 2014 Apr; 110():1-7. PubMed ID: 24468545
[TBL] [Abstract][Full Text] [Related]
5. Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.
Cechova K; Andel R; Angelucci F; Chmatalova Z; Markova H; Laczó J; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Ward DD; Hort J
J Alzheimers Dis; 2020; 73(1):247-257. PubMed ID: 31771052
[TBL] [Abstract][Full Text] [Related]
6. Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease.
Hashimoto R; Hirata Y; Asada T; Yamashita F; Nemoto K; Mori T; Moriguchi Y; Kunugi H; Arima K; Ohnishi T
Genes Brain Behav; 2009 Feb; 8(1):43-52. PubMed ID: 18786162
[TBL] [Abstract][Full Text] [Related]
7. BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease.
Lim YY; Villemagne VL; Laws SM; Ames D; Pietrzak RH; Ellis KA; Harrington KD; Bourgeat P; Salvado O; Darby D; Snyder PJ; Bush AI; Martins RN; Masters CL; Rowe CC; Nathan PJ; Maruff P;
Neurobiol Aging; 2013 Nov; 34(11):2457-64. PubMed ID: 23769397
[TBL] [Abstract][Full Text] [Related]
8. BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF.
Lim YY; Rainey-Smith S; Lim Y; Laws SM; Gupta V; Porter T; Bourgeat P; Ames D; Fowler C; Salvado O; Villemagne VL; Rowe CC; Masters CL; Zhou XF; Martins RN; Maruff P
Int Psychogeriatr; 2017 Nov; 29(11):1825-1834. PubMed ID: 28720165
[TBL] [Abstract][Full Text] [Related]
9. Influence of BDNF Val66Met on the relationship between cardiorespiratory fitness and memory in cognitively normal older adults.
Brown BM; Castalanelli N; Rainey-Smith SR; Doecke J; Weinborn M; Sohrabi HR; Laws SM; Martins RN; Peiffer JJ
Behav Brain Res; 2019 Apr; 362():103-108. PubMed ID: 30639507
[TBL] [Abstract][Full Text] [Related]
10. The associations of the BDNF and APOE polymorphisms, hippocampal subfield volumes, and episodic memory performance across the lifespan.
Malykhin NV; Travis S; Fujiwara E; Huang Y; Camicioli R; Olsen F
Hippocampus; 2020 Oct; 30(10):1081-1097. PubMed ID: 32573858
[TBL] [Abstract][Full Text] [Related]
11. The Combined Effect of APOE and BDNF Val66Met Polymorphisms on Spatial Navigation in Older Adults.
Laczó J; Cechova K; Parizkova M; Lerch O; Andel R; Matoska V; Kaplan V; Matuskova V; Nedelska Z; Vyhnalek M; Hort J
J Alzheimers Dis; 2020; 78(4):1473-1492. PubMed ID: 33325388
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease.
Nacmias B; Piccini C; Bagnoli S; Tedde A; Cellini E; Bracco L; Sorbi S
Neurosci Lett; 2004 Sep; 367(3):379-83. PubMed ID: 15337270
[TBL] [Abstract][Full Text] [Related]
13. Association study of brain-derived neurotrophic factor and apolipoprotein E polymorphisms and cognitive function in aged males without dementia.
Tsai SJ; Gau YT; Liu ME; Hsieh CH; Liou YJ; Hong CJ
Neurosci Lett; 2008 Mar; 433(2):158-62. PubMed ID: 18242855
[TBL] [Abstract][Full Text] [Related]
14. Executive function performance and change in aging is predicted by apolipoprotein E, intensified by catechol-O-methyltransferase and brain-derived neurotrophic factor, and moderated by age and lifestyle.
Sapkota S; Bäckman L; Dixon RA
Neurobiol Aging; 2017 Apr; 52():81-89. PubMed ID: 28131014
[TBL] [Abstract][Full Text] [Related]
15. The BDNF Val66Met polymorphism moderates the relationship between cognitive reserve and executive function.
Ward DD; Summers MJ; Saunders NL; Ritchie K; Summers JJ; Vickers JC
Transl Psychiatry; 2015 Jun; 5(6):e590. PubMed ID: 26125153
[TBL] [Abstract][Full Text] [Related]
16. Effects of COMT, DRD2, BDNF, and APOE Genotypic Variation on Treatment Efficacy and Cognitive Side Effects of Electroconvulsive Therapy.
Bousman CA; Katalinic N; Martin DM; Smith DJ; Ingram A; Dowling N; Ng C; Loo CK
J ECT; 2015 Jun; 31(2):129-35. PubMed ID: 25148110
[TBL] [Abstract][Full Text] [Related]
17. Ebbinghaus revisited: influences of the BDNF Val66Met polymorphism on backward serial recall are modulated by human aging.
Li SC; Chicherio C; Nyberg L; von Oertzen T; Nagel IE; Papenberg G; Sander T; Heekeren HR; Lindenberger U; Bäckman L
J Cogn Neurosci; 2010 Oct; 22(10):2164-73. PubMed ID: 19925205
[TBL] [Abstract][Full Text] [Related]
18. Effect of BDNF Val66Met on hippocampal subfields volumes and compensatory interaction with APOE-ε4 in middle-age cognitively unimpaired individuals from the ALFA study.
Vilor-Tejedor N; Operto G; Evans TE; Falcon C; Crous-Bou M; Minguillón C; Cacciaglia R; Milà-Alomà M; Grau-Rivera O; Suárez-Calvet M; Garrido-Martín D; Morán S; Esteller M; Adams HH; Molinuevo JL; Guigó R; Gispert JD;
Brain Struct Funct; 2020 Nov; 225(8):2331-2345. PubMed ID: 32804326
[TBL] [Abstract][Full Text] [Related]
19. APOE & BDNF polymorphisms interact to affect memory performance at baseline in adolescent athletes.
Riegler KE; Fink S; Guty ET; Echemendia RJ; Arnett PA; Merritt VC
Child Neuropsychol; 2023 Jul; 29(5):795-807. PubMed ID: 36268760
[TBL] [Abstract][Full Text] [Related]
20. APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease.
Lim YY; Villemagne VL; Laws SM; Pietrzak RH; Snyder PJ; Ames D; Ellis KA; Harrington K; Rembach A; Martins RN; Rowe CC; Masters CL; Maruff P
Mol Psychiatry; 2015 Nov; 20(11):1322-8. PubMed ID: 25288138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
